A detailed history of Df Dent & CO Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Df Dent & CO Inc holds 57,687 shares of MEDP stock, worth $23.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
57,687
Previous 58,244 0.96%
Holding current value
$23.2 Million
Previous $17.9 Million 30.59%
% of portfolio
0.31%
Previous 0.25%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$284.87 - $413.31 $158,672 - $230,213
-557 Reduced 0.96%
57,687 $23.3 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $96,696 - $132,889
-425 Reduced 0.72%
58,244 $17.9 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $11 Million - $14.1 Million
58,669 New
58,669 $14.1 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $1.07 Million - $1.47 Million
6,134 Added 7.13%
92,170 $17.3 Million
Q4 2022

Feb 15, 2023

SELL
$153.06 - $226.57 $2.26 Million - $3.35 Million
-14,791 Reduced 14.67%
86,036 $18.3 Million
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $1.14 Million - $1.44 Million
7,868 Added 8.46%
100,827 $15.8 Million
Q2 2022

Aug 15, 2022

SELL
$130.2 - $168.03 $1.55 Million - $2 Million
-11,915 Reduced 11.36%
92,959 $13.9 Million
Q1 2022

May 16, 2022

BUY
$138.87 - $214.31 $431,885 - $666,504
3,110 Added 3.06%
104,874 $17.2 Million
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $183,288 - $228,583
1,003 Added 1.0%
101,764 $22.1 Million
Q3 2021

Nov 15, 2021

BUY
$170.18 - $198.21 $952,837 - $1.11 Million
5,599 Added 5.88%
100,761 $19.1 Million
Q2 2021

Aug 16, 2021

BUY
$158.62 - $194.3 $2.55 Million - $3.12 Million
16,075 Added 20.33%
95,162 $16.8 Million
Q1 2021

May 17, 2021

BUY
$132.02 - $168.26 $10.4 Million - $13.3 Million
79,087 New
79,087 $13 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Df Dent & CO Inc Portfolio

Follow Df Dent & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Df Dent & CO Inc with notifications on news.